Clinical Trials Bite Off Chunk of CAR T Therapy Market
Clinical Trials Bite Off Chunk of CAR T Therapy Market
About a quarter of lymphoma patients eligible for the cancer treatments are opting for experimental—and free—options instead.
Clinical Trials Bite Off Chunk of CAR T Therapy Market
Clinical Trials Bite Off Chunk of CAR T Therapy Market

About a quarter of lymphoma patients eligible for the cancer treatments are opting for experimental—and free—options instead.

About a quarter of lymphoma patients eligible for the cancer treatments are opting for experimental—and free—options instead.

health insurance
Startups Plan the Health Data Gold Rush
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Catherine Offord | Dec 17, 2017
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers. 
Medical Labs Sue US Government Over Medicare Fees
Medical Labs Sue US Government Over Medicare Fees
Kerry Grens | Dec 12, 2017
The American Clinical Laboratory Association claims that scheduled reimbursements for tests are too low and could put small companies out of business.
Breaking: CDC's Prevention and Public Health Fund Could Be Axed
Breaking: CDC's Prevention and Public Health Fund Could Be Axed
Kerry Grens | May 4, 2017
If made law, the American Health Care Act passed today in the US House would eliminate the Obamacare-funded initiative.